The attention deficit hyperactivity disorder (ADHD) therapeutics market faces several inhibitors that challenge its growth and development. One of the primary obstacles is the complexity of diagnosing and treating ADHD. The symptoms of ADHD can vary significantly from person to person, making it difficult for healthcare providers to determine the most effective treatment. This variability often...